MR spectroscopy in radiation injury.
Detecting a new area of contrast enhancement in or in the vicinity of a previously treated brain tumor always causes concern for both the patient and the physician. The question that immediately arises is whether this new lesion is recurrent tumor or a treatment effect. The differentiation of recurrent tumor or progressive tumor from radiation injury after radiation therapy is often a radiologic dilemma regardless the technique used, CT or MR imaging. The purpose of this article was to review the utility of one of the newer MR imaging techniques, MR spectroscopy, to distinguish recurrent tumor from radiation necrosis or radiation injury.
Sundgren
P C
PC
Division of Neuroradiology, Department of Radiology, University of Michigan Health Systems, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA. sundgren@med.umich.edu
D000465:Algorithms; D015415:Biomarkers / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000517:prevention & control; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis* / Q000209:etiology*; D020266:Radiotherapy, Conformal / Q000009:adverse effects*
D015415:Biomarkers; D014408:Biomarkers, Tumor